Viewing StudyNCT00325507



Ignite Creation Date: 2024-05-05 @ 4:49 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00325507
Status: COMPLETED
Last Update Posted: 2020-10-19
First Post: 2006-05-10

Brief Title: Safety and Biological Activity of TroVax Vaccine Given With IL-2 in Renal Cell Carcinoma
Sponsor: Oxford BioMedica
Organization: Oxford BioMedica

Conditions & Keywords Data

Conditions:
Name
Carcinoma Renal Cell
Keywords:
Name View
Locally advanced or metastatic renal cell carcinoma View
renal cell carcinoma View
requiring IL-2 treatment View